OSLM
Outcome Studies
in Laboratory Medicine
guest
👤
Learn more about this platform
c
Categories
p
Projects
Trial protocol
Highlighted
Study Design
RCT
Cluster RCT
Observational
Model
Meta-analysis
Review
Guideline
Outcomes
Change patient management
Clinical outcomes
Economics
Operational efficiencies
Patient-centeredness
Safety
Guide Policy Making
Other
Uncategorized
Antibiotic Guidance
ACT Guided Heparinization
Cancer
COVID-19
Cardiovascular Disease
Diabetes
HIV POCT
Inflammatory Bowel Disease
Liver Disease
Kidney Disease
Newborn Screening
MALDI-TOF MS For Microorganism Identification
Preeclampsia
Pharmacogenetic and Pharmacogenomics
Therapeutic drug monitoring
Viscoelastic Testing
Please contact us for any suggestions
Zhen Zhao
Smeralda Skenderaj
Search
Search
Project:
Therapeutic drug monitoring
Categories:
RCT
Clinical outcomes
16 Publications
found
Reduced prescription of TNF-inhibitors in chronic arthritis based on therapeutic drug monitoring: A randomized controlled trial.
b
Scandinavian journal of rheumatology
September 1, 2023
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
RCT
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial Results.
b
Gastroenterology
June 1, 2022
p
Therapeutic drug monitoring
c
Clinical outcomes
RCT
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
b
JAMA
December 21, 2021
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
Patient-centeredness
RCT
Cost-Effectiveness of Therapeutic Drug Monitoring-Guided Adalimumab Therapy in Rheumatic Diseases: A Prospective, Pragmatic Trial.
b
Rheumatology and therapy
September 1, 2021
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
Economics
RCT
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients.
b
British journal of haematology
July 1, 2021
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
RCT
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
b
JAMA
May 4, 2021
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
RCT
Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial.
b
Scandinavian journal of gastroenterology
February 1, 2021
p
Therapeutic drug monitoring
c
Clinical outcomes
RCT
Randomized study of individualized pharmacokinetically-guided dosing of paclitaxel compared with body-surface area dosing in Chinese patients with advanced non-small cell lung cancer.
b
British journal of clinical pharmacology
October 1, 2019
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
RCT
Proactive Monitoring of Adalimumab Trough Concentration Associated With Increased Clinical Remission in Children With Crohn’s Disease Compared With Reactive Monitoring.
b
Gastroenterology
October 1, 2019
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
RCT
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease.
b
Gastroenterology
April 1, 2018
p
Therapeutic drug monitoring
c
Change patient management
Clinical outcomes
RCT
1
2
Next Page
